argenx SE (ARGX)
NASDAQ·Healthcare·Biotechnology
$775.59
-1.04%
Mkt Cap $45.82B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Oct 30, 2025 | $1.28B | $947.96M | -25.71% | $4.37 | $5.18 | +18.54% | — | — |
| Q2 2025 May 8, 2025 | $861.83M | $1.35B | +56.21% | $0.98 | $2.58 | +163.27% | — | — |
| Q1 2025 Mar 31, 2025 | — | $790.68M | — | — | $2.58 | — | — | — |
| Q4 2024 Oct 31, 2024 | $665.08M | $901.94M | +35.61% | $0.10 | $1.39 | +1290.00% | — | — |
| Q3 2024 Sep 30, 2024 | — | $573.24M | — | — | $1.39 | — | — | — |
| Q2 2024 May 9, 2024 | $563.91M | $757.68M | +34.36% | -$0.71 | -$1.04 | -46.48% | — | — |
| Q1 2024 Mar 31, 2024 | — | $401.00M | — | — | -$1.04 | — | — | — |
| Q4 2023 Oct 31, 2023 | — | $468.20M | — | -$1.48 | -$1.25 | +15.54% | — | — |
| Q3 2023 Sep 30, 2023 | — | $329.79M | — | — | -$1.25 | — | — | — |
| Q2 2023 Jun 21, 2023 | — | -$257.98M | — | — | $0.82 | — | — | — |
| Q2 2023 May 4, 2023 | — | $302.91M | — | -$2.34 | -$0.52 | +77.78% | — | — |
| Q4 2022 Oct 27, 2022 | $116.09M | $111.36M | -4.08% | -$3.50 | -$4.26 | -21.71% | — | — |
| Q4 2021 Oct 28, 2021 | $16.18M | $420.44M | +2498.54% | -$4.48 | -$4.40 | +1.79% | — | — |
| Q2 2021 May 14, 2021 | $36.25M | $22.64M | -37.54% | -$3.14 | -$0.81 | +74.20% | — | — |
| Q4 2020 Oct 22, 2020 | $35.94M | $30.52M | -15.08% | -$2.39 | -$3.39 | -41.84% | — | — |
| Q2 2020 May 14, 2020 | $51.71M | $31.29M | -39.50% | -$1.88 | -$2.06 | -9.57% | — | — |
| Q4 2019 Oct 24, 2019 | $32.84M | $51.30M | +56.20% | -$1.17 | -$0.66 | +43.59% | — | — |
| Q2 2019 May 9, 2019 | $82.15M | $8.73M | -89.37% | -$0.74 | $0.17 | +122.97% | — | — |
| Q4 2018 Oct 25, 2018 | $2.52M | $20.50M | +714.22% | -$0.68 | -$0.51 | +25.00% | — | — |
| Q2 2018 May 9, 2018 | $6.26M | $16.43M | +162.30% | -$0.38 | -$0.55 | -44.74% | — | — |